Copyright
©The Author(s) 2018.
World J Gastroenterol. Jun 28, 2018; 24(24): 2596-2604
Published online Jun 28, 2018. doi: 10.3748/wjg.v24.i24.2596
Published online Jun 28, 2018. doi: 10.3748/wjg.v24.i24.2596
Figure 2 Relative contents of the selected four miRNAs in the sera from patient with hepatocellular carcinoma in the validation phase.
The asterisks indicate significant differences from normal controls (P < 0.05). eP < 0.001. NC: Normal controls; HCC: Hepatocellular carcinoma.
- Citation: An Y, Gao S, Zhao WC, Qiu BA, Xia NX, Zhang PJ, Fan ZP. Novel serum microRNAs panel on the diagnostic and prognostic implications of hepatocellular carcinoma. World J Gastroenterol 2018; 24(24): 2596-2604
- URL: https://www.wjgnet.com/1007-9327/full/v24/i24/2596.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i24.2596